Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

0 of 8 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 4

3(42.9%)

Phase 2

1(14.3%)

7Total

N/A(3)

Phase 4(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07042165Phase 4Recruiting

Treatment of Bile Acid Diarrhoea With Atorvastatin

Role: collaborator

NCT05812742Not ApplicableCompleted

Chasing Biomarkers in Post-concussion Syndrome

Role: collaborator

NCT04614207Completed

Cerebral Palsy & Predictors of Physical Activity

Role: collaborator

NCT03847545Not ApplicableCompleted

Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique

Role: collaborator

NCT03541239Not ApplicableCompleted

Immune Modulation by Ischemic Pre-conditioning in Healthy Individuals: Intracellular Signalling in Regulatory Cells

Role: collaborator

NCT00639054Completed

The Molecular Characterization of Multiple Myeloma at Relapse

Role: collaborator

NCT01359878Phase 2Completed

Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial

Role: collaborator

NCT00168571Phase 4Completed

Long-term Follow-up of Measles Antibodies

Role: collaborator

NCT00168545Phase 4Completed

Immunology of Non-specific Effects of Vaccine

Role: collaborator

All 9 trials loaded